STADA Arzneimittel AG

Explore STADA

As a pharmaceutical and healthcare company, STADA takes responsibility for the safety of its products and the well-being of patients. In our 2024 Sustainability Report, we outline our approach to sustainability, share our ESG commitments, and report on the progress we have made.

Diversity & Inclusion

Our culture thrives on empowering our people to bring forward their unique and diverse experiences. Thought leadership article by Simone Berger, CPO.

Trusted Partner

Central to STADA's commitment to caring for people's health through consumer healthcare products, specialty medicines and generics are close partnerships to improve health globally.

Grow Your Own Way

STADA’s Employer Brand – creatively brought to life by our global talents in the "Get Growing Talent Program".

Parkinson’s Disease

Raising awareness for the world’s second most common neurodegenerative disease. By 2050, 25 million people could be affected. Parkinson’s goes beyond movement – it impacts everyday life and mental health. At STADA, we stand for progress, solidarity and hope.

Three-pillar Strategy

The company focuses on consumer healthcare products, generics and speciality medicines.

Your opportunity for success with STADA

We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.

Careers at STADA

Latest news

01/09/2025

Bain Capital and Cinven to sell majority stake in STADA to CapVest

01/09/2025

CapVest to acquire majority stake in STADA from Bain Capital and Cinven

28/08/2025

STADA sees strong sales and earnings growth in H1

22/08/2025

Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab

07/07/2025

STADA brings in Henshaw from Biogen to head Specialty as Kim leads Western Europe

26/06/2025

STADA Health Report 2025: A healthy life – desired by many, lived by only half of Europeans

03/06/2025

STADA’s continued, resilient growth leads to record earnings in Q1

07/03/2025

STADA’s growth journey continues in 2024

09/01/2025

STADA sets course for the future- experienced healthcare manager Andreas Fibig to become Chairman of the Board

STADA Voices

Miguel Pagan Fernandez

Frank Staud

Volker Sydow

Stéphane Jacqmin

Dr. Christoph Dengler

Christos Gallis

Read our news

Consumer Healthcare products

STADA is the fourth-largest consumer healthcare company in Europe and markets products internationally in all relevant healthcare categories. The most significant drivers are the Local Hero Brands, strong regional brands and newly acquired products that successfully complement the existing product range.

View our brands

Improving access to life-changing treatments for patients worldwide

Specialty Pharmaceuticals are medicines, that give patients access to innovative treatment options, especially for chronic, severe or rare diseases.

STADA’s Specialty portfolio includes innovative treatments for conditions such as Parkinson’s disease and a rare kidney disease, as well as a range of biologic medicines across uses in cancer, eyecare and autoimmune conditions.

Through partnerships, we are establishing a sustainable specialty pipeline to deliver on our purpose of “Caring for People’s Health as a Trusted Partner”.

Specialty Pharmaceuticals

Affordable generics have been the backbone of STADA since 1895

As a major player in the generics sector, we support patient care with affordable medicines. This is especially true in Europe, where STADA ranks as the fourth-largest manufacturer and supplier of generics in terms of sales.

Seven out of ten medicines prescribed in Europe are generic, but these account for only about 30% of all pharmaceutical expenditure.

Generics

Our purpose is ‘Caring for People’s Health as a Trusted Partner’

At STADA, this purpose unites all employees globally as a One STADA team with the aim of bringing health to society. It guides STADA's people in their day-to-day business –

and drives the company’s ambition to be the partner of choice in Consumer Healthcare, Generics and Specialty.

Our purpose

STADA further builds its bone-health and oncology offering

STADA Expands Specialty Biosimilars Portfolio

CapVest to acquire majority stake in STADA from Bain Capital and Cinven

Bain Capital and Cinven to sell majority stake in STADA to CapVest

Bio-Thera and STADA Extend Biosimilars Alliance

Sustainability Report 2024

Explore STADA

Your opportunity for success with STADA

Latest news

STADA Voices

Consumer Healthcare products

Improving access to life-changing treatments for patients worldwide

Affordable generics have been the backbone of STADA since 1895

Our purpose is ‘Caring for People’s Health as a Trusted Partner’

Products

Company

STADA further builds its bone-health and oncology offering

STADA Expands Specialty Biosimilars Portfolio

CapVest to acquire majority stake in STADA from Bain Capital and Cinven

Bain Capital and Cinven to sell majority stake in STADA to CapVest

Bio-Thera and STADA Extend Biosimilars Alliance

Sustainability Report 2024

Explore STADA

Your opportunity for success with STADA

Growth mindset: Our people are our ambassadors

Latest news

STADA Voices

Consumer Healthcare products

Improving access to life-changing treatments for patients worldwide

Affordable generics have been the backbone of STADA since 1895

Our purpose is ‘Caring for People’s Health as a Trusted Partner’